LKB1 is the major upstream kinase phosphorylating AMPK, which has been well-defined as a tumor suppressor, since its loss-of-function mutations are commonly detected and directly induce the oncogenesis in some malignancies, especially in NSCLCs27–31. Here, PRKAA1 is linked to neoplasm.